Health
Early monoclonal antibody therapies beneficial for COVID-19, finds study – News-Medical.Net
A team of scientists recently conducted a large-scale study at Northwell Health, New York, USA, to evaluate the efficacy of neutralizing monoclonal antibody (MAB)…
A team of scientists recently conducted a large-scale study at Northwell Health, New York, USA, to evaluate the efficacy of neutralizing monoclonal antibody (MAB) therapies in preventing disease progression among patients with mild to moderate coronavirus disease 2019 (COVID-19). The findings reveal that the timing of initiating MAB therapy is a crucial factor in determining its efficacy against COVID-19. The study is currently available on the medRxiv* preprint server.
Background
Since the emergence…
-
Noosa News24 hours agoThis 42-Kilometre Walking Trail on the NSW North Coast Weaves Through Ancient Rainforest, Volcanic Mountains and Spectacular Waterfalls
-
Noosa News22 hours agoQueensland cop cleared by court of stealing watches during anti-gang raid
-
Noosa News22 hours agoEaster weather forecast: What to expect in Sydney, Perth, Melbourne, Brisbane, Adelaide and Canberra
-
Noosa News23 hours agoAnother power station confirmed offline as political fallout continues amid cultural issues